Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Dual 5-LO and COX-2 inhibitors for inflammatory disorders

Sep. 3, 1998

Zeneca patents new peptides for autoimmune/inflammatory disorders

Sep. 2, 1998

New treatment for osteoarthritis pain now available in the U.K.

Aug. 31, 1998

New agent for the prevention of osteoarthritis identified at Roche Bioscience

Aug. 27, 1998

MMP inhibitors under investigation at Pharmacia & Upjohn

Aug. 27, 1998

FDA gives priority review status to COX-2 inhibitor

Aug. 27, 1998

Selective MMP-3 inhibitor PS-508 described at ACS meeting

Aug. 26, 1998

ACS news flash: Rhone-Poulenc Rorer studies dual PDE4/MMP inhibitors

Aug. 26, 1998

British Biotech claims MMP inhibitors for blocking connective tissue degradation

Aug. 26, 1998

FDA advisory committee meeting scheduled to review Enbrel BLA

Aug. 25, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...